Features

Our editorial board comprises a specialist group of leading industry figures who, in conjunction with the World Pharmaceutical Frontiers editorial team, identify the main drivers of the industry helping to produce regular, thought-provoking opinion pieces on the latest issues, challenges and developments.

Latest World Pharmaceuticals Feature

Safety and urgency
24 May, 2023
Cell and gene therapies raise more challenges for quality control...
> read more

It's better together 24 May, 2023 Cell and gene therapies are altering what’s possible in the world of medicine – but the scope of their implementation depends on the scale of manufacturing. It is to this end...

Helping the medicine go down 24 May, 2023 Excipients are often described as inert or inactive, in the context of formulating drugs. But this is only partially true, as while they don’t interact with proteins, enzymes,...

Eyes on the prize 24 May, 2023 The idea of an intelligent supply chain with end-to-end visibility has been talked about for years. But how much of this potential has been realised in the supply chain of...

Reducing risk, improving quality 24 May, 2023 There’s always risk involved when transporting cargo, but when the transported product is highly reactive to temperature that risk can increase dramatically – especially for the...

Crossing the barrier 24 May, 2023 The blood-brain barrier protects against invasion by blood-borne pathogens in an effort to safeguard the microenvironment that sustains complex neural function. But what happens when...

Extending the effect 24 May, 2023 Chronic diseases often come with a burden of administering medication routinely throughout the week, or in many cases, the day. Proponents of long-acting injectables wish to change...

Read the small print 09 September, 2022 The labels on drug packaging are one of the main drug/patient interfaces in a clinical trial, especially one that is conducted remotely. Despite this, confusion involving packaging...

Seeking value in serialization 16 August, 2022 The concept of serialisation was primarily a response to the counterfeit drug challenge of the early 2000s. Though technological advances and regulatory development never fully...

Trial and error 16 August, 2022 Covid-19 transformed clinical trials practically overnight, with remote testing and quicker approvals suddenly becoming a reality the world over. These shifts aren’t hard to...

A harmony of interests 16 August, 2022 Data sets obtained through collaboration across multiple countries are an important way to strengthen research findings, and in some cases can be necessary to study rare diseases due...

The right temperature 16 August, 2022 Temperature control can be the difference between a supply of usable products and a shortfall that delays a trial and increases the overall cost for sponsors. This level of risk...

Backwards about moving forwards 16 August, 2022 Clinical trials have long been famous for their sophistication and lengthy timespans. But traditionally, organisers have paid less attention to what happens once the research is done...

Flex and adapt: the new onsite model 16 August, 2022 As some companies move part of their workforce back into the office to afford workers the flexibility to work in a hybrid model, new skills and considerations must be developed to...

Data is king 16 August, 2022 The advent of dedicated software has made it easier to keep track of the large volume of information involved in running a clinical trial. Yet the multiplicity of requirements...

Track and trace 03 June, 2022 There is nothing like a pandemic for demonstrating the necessity for serialisation, interoperability, and more advanced analytics and tracking. Tim Gunn asks Rob Handfield, the...

Outsource and intake 03 June, 2022 For decades, pharmaceutical companies have relied on contract development and manufacturing companies (CDMOs) to develop drugs. But though these third-party contractors proved their...

Double agents 03 June, 2022 Looking at a vial of liquid or a solid pill, it’s easy to see pharmaceuticals as simple objects rather than a complex array of chemicals and raw materials, delicately balanced to...

The struggle to supply 03 June, 2022 Pharmaceutical supply chains are still reacting to the pressures of the pandemic, though they have mostly held steady and avoided many of the potential risks. The stresses placed...

Good things, small packages 03 June, 2022 Containers have been an inescapable part of the pharma supply chain forever – but it’s only with the rise of sophisticated new treatments, and the consequences of the pandemic,...


View all features A-Z


Privacy Policy
We have updated our privacy policy. In the latest update it explains what cookies are and how we use them on our site. To learn more about cookies and their benefits, please view our privacy policy. Please be aware that parts of this site will not function correctly if you disable cookies. By continuing to use this site, you consent to our use of cookies in accordance with our privacy policy unless you have disabled them.
cachename:Featurescachekey:rd-1665407042_727740091_rd-488908060_1460672566_ap1460672566_727740091_1595691727